KRAS Gene Mutation Analysis
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
Lead, Blood
Lipase, Serum
Nickel, Serum
Anti-Streptolysin O (ASO)
C-Reactive Protein, High Sensitivity (hsCRP)
Aluminum, Serum
Neurotrophic Receptor Tyrosine Kinase 2 (NTRK2) Gene Mutation Analysis (Translocation)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
Medical Test
Methodology
Access to
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication (OvaNext®)
is restricted.
Sign up now
Loading...